September 28, 2023

Weekly Review: Dow Leads Growth with Tesla, Netflix, and Taiwan Semi – Shiv Telegram Media

Title: Stock Market Reaches New Highs despite Earnings-Related Sell-Offs

The stock market rally displayed its resilience this week as the Dow Jones, S&P 500, and Nasdaq composite all reached impressive 52-week highs. However, the Nasdaq experienced a substantial sell-off on Thursday, eliminating its weekly gains. Reports of earnings-related sell-offs from Tesla, Netflix, and Taiwan Semiconductor contributed to this downturn, overshadowing the overall market ascension.

Despite mixed economic data, bank stocks managed to thrive on the back of positive earnings reports. Johnson & Johnson’s strong earnings performance helped buoy the Dow. Treasury yields experienced a rebound after a steep decline earlier in the month, offering some relief to investors.

Although there were signs of improvement in the job market, such as a decrease in new claims for jobless benefits during the week through July 15, industrial production suffered a setback in June, primarily due to a decline in auto production. However, the sentiment among homebuilders continued to rise for the seventh consecutive month in July, despite a slight slip in building permits and housing starts in June.

Tesla’s reported 20% increase in earnings-per-share was overshadowed by falling gross margins, which caused its stock price to tumble. Similarly, semiconductor stocks took a hit following earnings reports from ASML and Taiwan Semiconductor, indicating weakness in the market. On the other hand, major tech players like Microsoft and Salesforce made announcements regarding pricing plans for their artificial intelligence offerings.

While Netflix exceeded subscriber growth estimates, the company’s sales and revenue outlook disappointed investors. Nonetheless, Bank of America, Morgan Stanley, and Goldman Sachs continued their upward trajectory on the back of positive earnings. Charles Schwab’s earnings saw a decline, but still narrowly managed to surpass expectations.

Amidst the earnings season, several companies made headlines with promising or disappointing reports. Johnson & Johnson and Abbott Laboratories experienced notable surges on the back of their earnings, with J&J raising its full-year outlook. Emerging biotech giants Argenx and BridgeBio Pharma saw their stocks soar following positive clinical study news, while Apellis Pharmaceuticals faced a significant decline due to reports of side effects from an approved drug.

Lockheed Martin reported robust earnings and sales, but its shares slumped due to other market factors. Novartis experienced a breakthrough as its stock prices soared following strong earnings and sales reports. Toast and Ford Motor also experienced notable price moves during the week.

In an attempt to reduce their debt, Carvana announced a debt reduction deal alongside better-than-expected quarterly results. Despite a drop in earnings per share, Freeport-McMoRan managed to achieve a sales gain. SAP, the software giant, reported a rise in operating profit and revenue.

Intuitive Surgical faced a decline in stock prices as procedure growth moderated, despite surpassing sales and profit expectations.

Overall, the stock market rally remained resilient despite earnings-related sell-offs, demonstrating the strong resolve of investors amidst varying economic data and market fluctuations.

Word Count: 412